1. Haak, T, Hanaire, H, Ajjan, R, et al. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther 2017; 8(1): 55–73.
Google Scholar | Crossref | Medline2. Beck, RW, Riddlesworth, TD, Ruedy, K, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily injections. A randomized trial. Ann Intern Med 2017; 167(6): 365–374.
Google Scholar | Crossref | Medline3. Yaron, M, Roitman, E, Aharon-Hananel, G, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care 2019; 42(7): 1178–1184.
Google Scholar | Crossref | Medline4. Kröger, J, Fasching, P, Hanaire, H. Three European retrospective real-world chart review studies to determine the effectiveness of flash glucose monitoring on HbA1c in adults with type 2 diabetes. Diabetes Ther 2020; 11(1): 279–291.
Google Scholar | Crossref | Medline5. Vigersky, RA, Fonda, SJ, Chellappa, M, et al. Sort and long term effect of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care 2012; 35: 32–38.
Google Scholar | Crossref | Medline | ISI6. Abbott, Diabetes Care. Data on file 2015.
Google Scholar7. Miller, E, Brandner, L, Wright, E. 84-LB: HbA1c reduction after initiation of the FreeStyle Libre System in type 2 diabetes patients on long-acting insulin or noninsulin therapy. Diabetes 2020; 69(Suppl. 1). https://doi.org/10.2337/db20-84-LB (accessed 26 May 2021).
Google Scholar8. Evans, M, Welsh, Z, Ells, S, et al. The impact of flash glucose monitoring on glycaemic control as measured by HbA1c: a meta-analysis of clinical trials and real-world observational studies. Diabetes Ther. 2020; 11(1): 83–95.
Google Scholar | Crossref | Medline9. Castellana, M, Parisi, C, Di Molfetta, S, et al. Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis. BMJ Open Diabetes Res Care 2020; 8(1): e001092.
Google Scholar | Crossref | Medline10. Ilany, J, Bhandari, H, Nabriski, D, et al. Effect of prandial treatment timing adjustment, based on continuous glucose monitoring, in patients with type 2 diabetes uncontrolled with once-daily basal insulin: a randomized, phase IV study. Diabetes Obes Metab 2018; 20(5): 1186–1192.
Google Scholar | Crossref | Medline11. Ray, KK, Kendall, DM, Zhao, Z, et al. A multinational observational study assessing insulin use: understanding the determinants associated with progression of therapy. Diabetes Obes Metab 2019; 21(5): 1101–1110.
Google Scholar | Crossref | Medline12. Berard, L, Antonishyn, N, Arcudi, K, et al. Insulin matters: a practical approach to basal insulin management in type 2 diabetes. Diabetes Ther 2018; 9(2): 501–519.
Google Scholar | Crossref | Medline